FEASIBILITY AND EFFICACY OF INDUCTION DOCETAXEL, CISPLATIN, AND 5-FLUOROURACIL CHEMOTHERAPY COMBINED WITH CISPLATIN CONCURRENT CHEMORADIOTHERAPY FOR NONMETASTATIC STAGE IV HEAD-AND-NECK SQUAMOUS CELL CARCINOMAS


Prestwich R. J. , Oeksuez D. , Dyker K., Coyle C., Sen M.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, cilt.81, sa.4, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 81 Konu: 4
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1016/j.ijrobp.2011.03.043
  • Dergi Adı: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Özet

Purpose: To report the experience of treating selected fit patients with locally advanced head-and-neck squamous cell carcinoma with three cycles of induction TPF (docetaxel 75 mg/m(2), cisplatin 75 mg/m(2), 5-fluorouracil 750 mg/m(2), Days 2-5) followed by concurrent three-weekly bolus cisplatin 100 mg/m(2) chemoradiotherapy.